Home/Filings/4/0001179110-20-007730
4//SEC Filing

Toselli Richard M. 4

Accession 0001179110-20-007730

CIK 0001292519other

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 6:35 PM ET

Size

5.3 KB

Accession

0001179110-20-007730

Insider Transaction Report

Form 4
Period: 2020-06-19
Toselli Richard M.
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2020-06-19$1.70/sh15$266,054 total
Footnotes (1)
  • [F1]Represents shares sold by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2018 to satisfy tax withholding obligations applicable to the vesting of 50 stock-settled restricted stock units ("RSUs"). The vesting schedule for the RSUs was amended on June 11, 2019, and the remaining shares underlying the unvested RSUs vest in equal semi-annual installments on June 18 and December 18 until fully vested on December 18, 2021.

Issuer

INVIVO THERAPEUTICS HOLDINGS CORP.

CIK 0001292519

Entity typeother

Related Parties

1
  • filerCIK 0001710549

Filing Metadata

Form type
4
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 6:35 PM ET
Size
5.3 KB